Healio9m
Lumevoq for LHON yields sustained visual acuity improvements at 5 years in phase 3 trial
A one-time injection of Lumevoq demonstrated sustained visual acuity improvements with a favorable safety profile at 5 years in patients with Leber hereditary optic neuropathy, according to a press ...
Futurism on MSN49m
Evidence Is Growing That Ozempic Can Cause Blindness
As drugs like Ozempic and Mounjaro continue to skyrocket in usage, doctors are encountering more and more cases linking them ...
Eye Doctors Are Finding New Links Between Ozempic and Vision Problems
The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...
ophthalmologyadvisor1d
Weight-Loss Drugs May Elevate NAION Risk, Although Causal Link Remains Unproven
Weight-loss drugs such as semaglutides or tirzepatides may raise patients’ risk of nonarteritic anterior ischemic optic ...
Hosted on MSN1d
GenSight’s Optic Neuropathy gene therapy sustains efficacy over five years
The five-year trial saw patients who received a single injection of Lumevoq sustaining clinical recovery in a rare condition ...